Benzinga | Aug 10, 2020 08:32AM EDT

Morgan Stanley Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $53

Morgan Stanley maintains Axonics Modulation Tech (NASDAQ:AXNX) with a Overweight and raises the price target from $42 to $53.